Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy
© 2024 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology..
This report presents the case of a 42-year-old Japanese woman with recurrent hormone receptor-positive breast cancer who developed eosinophilic pneumonia (EP) during treatment with abemaciclib combined with endocrine therapy. Seven years after a radical surgery and definite diagnosis of Stage I breast cancer, her cancer recurred with metastases to multiple organs. Initially treated with abemaciclib plus letrozole and goserelin for 3 months, she developed EP, which improved after the discontinuation of anti-cancer treatment and the administration of prednisolone. However, EP occurred again upon the reintroduction of endocrine therapy (i.e., letrozole and goserelin). It improved gradually with the suspension of endocrine therapy and the re-administration of prednisolone. This case underscores the need for further research into the prevention and management of EP in patients receiving abemaciclib with endocrine therapy for advanced breast cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Respirology case reports - 12(2024), 3 vom: 29. März, Seite e01320 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ogata, Hiroaki [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Abemaciclib |
|---|
| Anmerkungen: |
Date Revised 09.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/rcr2.1320 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369452437 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369452437 | ||
| 003 | DE-627 | ||
| 005 | 20240309232541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240308s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/rcr2.1320 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1321.xml |
| 035 | |a (DE-627)NLM369452437 | ||
| 035 | |a (NLM)38455504 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ogata, Hiroaki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. | ||
| 520 | |a This report presents the case of a 42-year-old Japanese woman with recurrent hormone receptor-positive breast cancer who developed eosinophilic pneumonia (EP) during treatment with abemaciclib combined with endocrine therapy. Seven years after a radical surgery and definite diagnosis of Stage I breast cancer, her cancer recurred with metastases to multiple organs. Initially treated with abemaciclib plus letrozole and goserelin for 3 months, she developed EP, which improved after the discontinuation of anti-cancer treatment and the administration of prednisolone. However, EP occurred again upon the reintroduction of endocrine therapy (i.e., letrozole and goserelin). It improved gradually with the suspension of endocrine therapy and the re-administration of prednisolone. This case underscores the need for further research into the prevention and management of EP in patients receiving abemaciclib with endocrine therapy for advanced breast cancer | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a abemaciclib | |
| 650 | 4 | |a breast cancer | |
| 650 | 4 | |a eosinophilic pneumonia | |
| 650 | 4 | |a goserelin | |
| 650 | 4 | |a letrozole | |
| 700 | 1 | |a Koga, Chinami |e verfasserin |4 aut | |
| 700 | 1 | |a Yanagihara, Toyoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Moriuchi, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Enokizu-Ogawa, Aimi |e verfasserin |4 aut | |
| 700 | 1 | |a Ishimatsu, Akiko |e verfasserin |4 aut | |
| 700 | 1 | |a Otsuka, Junji |e verfasserin |4 aut | |
| 700 | 1 | |a Taguchi, Kazuhito |e verfasserin |4 aut | |
| 700 | 1 | |a Moriwaki, Atsushi |e verfasserin |4 aut | |
| 700 | 1 | |a Tokunaga, Eriko |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshida, Makoto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respirology case reports |d 2013 |g 12(2024), 3 vom: 29. März, Seite e01320 |w (DE-627)NLM244269440 |x 2051-3380 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g number:3 |g day:29 |g month:03 |g pages:e01320 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/rcr2.1320 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2024 |e 3 |b 29 |c 03 |h e01320 | ||